Document Classification

Section Type: METHODS

Text: Patients with metastatic pancreatic cancer were randomly assigned to one of the following four regimens : gemcitabine 1, 000 mg/m (2) on days 1, 8, and 15 with cisplatin 50 mg/m (2) on days 1 and 15 (arm A) ; gemcitabine 1, 500 mg/m (2) at a rate of 10 mg/m (2) / min on days 1, 8, and 15 (arm B) ; gemcitabine 1, 000 mg/m (2) with docetaxel 40 mg/m (2) on days 1 and 8 (arm C) ; or gemcitabine 1, 000 mg/m (2) with irinotecan 100 mg/m (2) on days 1 and 8 (arm D).